An economic analysis of the universal varicella vaccination program in the United States

The Journal of Infectious Diseases
Fangjun ZhouJane Seward

Abstract

Frequent varicella outbreaks with sizable impact on the US public health system have continued to occur despite the success of the country's 1-dose varicella vaccination program. The Advisory Committee on Immunization Practices recently recommended adding a routine second dose of varicella vaccine and weighed economic projections as well as public health goals in their deliberations. This decision-tree-based analysis was conducted to evaluate the economic impact of the projected 2-dose varicella vaccination program as well as the existing 1-dose program. The analysis used population-based vaccination coverage and disease incidence data to make projections for a hypothetical US birth cohort of 4,100,000 infants born in 2006. Compared with no vaccination, both the 1-dose program (societal benefit-cost ratio [BCR], 4.37) and 2-dose program (BCR, 2.73) were estimated to be cost saving from the societal perspective. Compared with the 1-dose program, the incremental second dose was not cost saving (societal incremental BCR, 0.56). The incremental cost-effectiveness ratio for the second dose was $343 per case prevented, or approximately $109,000 per quality-adjusted life-year saved, and these results were sensitive to assumptions abou...Continue Reading

References

Oct 18, 1995·JAMA : the Journal of the American Medical Association·H S MargolisJ A Arevalo
Jun 1, 1994·The Journal of Pediatrics·D M HuseG Oster
Aug 4, 1999·JAMA : the Journal of the American Medical Association
Oct 16, 1999·Vaccine·P A ScuffhamM A Burgess
Mar 25, 2000·JAMA : the Journal of the American Medical Association·T A LieuH R Shinefield
Jul 29, 2000·The Journal of Infectious Diseases·P A MeyerM Wharton
Sep 9, 2000·JAMA : the Journal of the American Medical Association·R P WiseP R Krause
Jan 23, 2002·Vaccine·M Brisson, W J Edmunds
Feb 7, 2002·JAMA : the Journal of the American Medical Association·Jane F SewardMelinda Wharton
Oct 24, 2002·The Pediatric Infectious Disease Journal·Karin GalilJane Seward
Sep 23, 2003·Archives of Disease in Childhood·M Brisson, W J Edmunds
Jan 15, 2004·The Journal of Infection·G M Ginsberg, E Somekh
Feb 12, 2004·The Pediatric Infectious Disease Journal·Barbara KuterUNKNOWN Study Group for Varivax
Mar 3, 2004·Pediatrics·Barna D TugwellPaul R Cieslak
Apr 24, 2004·The Journal of Infectious Diseases·Fangjun ZhouMary M McCauley
Feb 4, 2005·The New England Journal of Medicine·Huong Q NguyenJane F Seward
Aug 18, 2005·JAMA : the Journal of the American Medical Association·Fangjun ZhouAbigail Shefer
Dec 7, 2005·Archives of Pediatrics & Adolescent Medicine·Fangjun ZhouRafael Harpaz
Dec 22, 2005·Australian and New Zealand Journal of Public Health·Heather F GiddingMargaret A Burgess
Jan 10, 2006·Journal of Paediatrics and Child Health·K K MacartneyM A Burgess
Jun 1, 2006·Pediatrics·Aaron E Carroll, Stephen M Downs
May 3, 2008·The Journal of Infectious Diseases·Jessica LeungJane F Seward
May 3, 2008·The Journal of Infectious Diseases·Jane F SewardMarietta Vázquez

❮ Previous
Next ❯

Citations

Oct 3, 2009·Epidemiology and Infection·M KarhunenK Auranen
Jan 13, 2010·Clinical Microbiology Reviews·D Scott Schmid, Aisha O Jumaan
Sep 10, 2009·BMC Infectious Diseases·Vincenzo BaldoRenzo Trivello
May 30, 2009·BMC Medicine·Paolo BonanniPeter Wutzler
Jun 10, 2010·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Kevin PottieUNKNOWN coauthors of the Canadian Collaboration for Immigrant and Refugee Health
Jan 15, 2014·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·D Moreno-PérezUNKNOWN Comité Asesor de Vacunas de la Asociación Española de Pediatría
Aug 13, 2013·Epidemiology and Infection·J Y C ChanA Lee
Dec 12, 2012·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·D Moreno-PérezUNKNOWN Comité Asesor de Vacunas de la Asociación Española de Pediatría, España
Mar 30, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Michael HerdmanNancy Devlin
Jul 14, 2010·The Journal of Allergy and Clinical Immunology·Jonathan I SilverbergTamar A Smith-Norowitz
Mar 6, 2016·Vaccine·Tetsushi YoshikawaMasahiro Ohashi
Mar 23, 2011·Pediatric Annals·James H Conway, Tiffany Green
Jun 5, 2015·Journal of Paediatrics and Child Health·Sophie Chien-Hui WenElizabeth Wilson
Jun 10, 2011·American Journal of Obstetrics and Gynecology·Evan R MyersGeeta K Swamy
Jul 1, 2011·Journal of Health Economics·Jason Abrevaya, Karen Mulligan
Jul 5, 2013·Human Vaccines & Immunotherapeutics·Brigid UnimGiuseppe La Torre
Dec 9, 2014·Human Vaccines & Immunotherapeutics·Silvio TafuriRosa Prato
Dec 3, 2014·The Journal of Allergy and Clinical Immunology·Sylvia BrandtRob McConnell
Jul 28, 2016·Human Vaccines & Immunotherapeutics·Xuan DengYanli Ma
Jan 21, 2010·Cadernos de saúde pública·Patrícia Coelho de SoárezAna Marli Christovan Sartori
Aug 6, 2018·Archives of Disease in Childhood. Education and Practice Edition·Sebastian J Gray, Katrina Cathie
May 18, 2016·The Pediatric Infectious Disease Journal·Jared DitkowskyTamar A Smith-Norowitz
Oct 18, 2010·Canada Communicable Disease Report = Relevé Des Maladies Transmissibles Au Canada·Alexia CampbellUNKNOWN approved by NACI.
Jan 8, 2021·Frontiers in Public Health·Caroline E WagnerRamanan Laxminarayan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.